Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129

The coronavirus disease 2019 (COVID-19) pandemic has been as unprecedented as unexpected, affecting more than 105 million people worldwide as of 8 February 2020 and causing more than 2.3 million deaths according to the World Health Organization (WHO). Not only affecting the lungs but also provoking...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cardiovasc Res
Autores principales: Badimon, Lina, Robinson, Emma L, Jusic, Amela, Carpusca, Irina, deWindt, Leon J, Emanueli, Costanza, Ferdinandy, Péter, Gu, Wei, Gyöngyösi, Mariann, Hackl, Matthias, Karaduzovic-Hadziabdic, Kanita, Lustrek, Mitja, Martelli, Fabio, Nham, Eric, Potočnjak, Ines, Satagopam, Venkata, Schneider, Reinhard, Thum, Thomas, Devaux, Yvan
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2021
Materias:
Reviews
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8083253/
https://ncbi.nlm.nih.gov/pubmed/33839767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvab094
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares